Smarter. Stronger. Together. Progressing Toward Optimal CLL Care Through Healthcare Professional and Patient Education

As CLL treatment paradigms continue to shift and become more complex, it is essential to provide patients with education on available treatment options and to engage in open discussions about their care. In this expert commentary, best practices on these concepts are discussed.

Jennifer Woyach, MD Released: November 17, 2021

Review an expert discussion of investigational treatment strategies for patients with chronic lymphocytic leukemia, including novel BTK and PI3K inhibitors, combination treatment with BTK and BCL-2 inhibitors, and CAR T-cell therapy.

Shuo Ma, MD, PhD Released: April 21, 2022

In this commentary, an expert faculty discusses key considerations and shared decision-making in choosing treatment for a patient with CLL.

Lindsey Roeker, MD Released: July 7, 2022